Autologous mesenchymal stem cells in chronic spinal cord injury

Spinal cord injury (SCI) occurs in the most productive part of life. Treatment options for treatment of chronic SCI are few and have limited impact on clinical outcome. Central nervous system (CNS) has limited intrinsic regeneration capability. The study included patients with chronic complete SCI. Previously harvested autologous mesenchymal stem cells were administered at the site of injury after a laminectomy. Follow-up was done by a neutral examiner not involved in the surgery every 3 months. One patient had improvement in motor power. Two patients had a patchy improvement in pin prick sensation below the level of injury. Three different, progressively increasing doses did not result in improvement in the clinical outcome. Though the administration of allogenic human mesenchymal stem cells is safe in patients with SCI, it may not be efficacious; especially in patients with chronic SCI.

[1]  J. Neuwirth,et al.  Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. , 2006, Cell transplantation.

[2]  B. Stokes,et al.  Cellular inflammatory response after spinal cord injury in sprague‐dawley and lewis rats , 1997, The Journal of comparative neurology.

[3]  H. Winn,et al.  Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. , 1997, JAMA.

[4]  P. Jendelová,et al.  Magnetic Resonance Tracking of Implanted Adult and Embryonic Stem Cells in Injured Brain and Spinal Cord , 2005, Annals of the New York Academy of Sciences.

[5]  Judith M Curran,et al.  The differentiation of bone marrow mesenchymal stem cells into chondrocyte-like cells on poly-L-lactic acid (PLLA) scaffolds. , 2006, Biomaterials.

[6]  M. Fehlings,et al.  Current status of experimental cell replacement approaches to spinal cord injury. , 2008, Neurosurgical focus.

[7]  B. Choi,et al.  Treatment of complete spinal cord injury patients by autologous bone marrow cell transplantation and administration of granulocyte-macrophage colony stimulating factor. , 2005, Tissue engineering.

[8]  H. Blau,et al.  From marrow to brain: expression of neuronal phenotypes in adult mice. , 2000, Science.

[9]  J. Widenfalk,et al.  Neurotrophic Factors and Receptors in the Immature and Adult Spinal Cord after Mechanical Injury or Kainic Acid , 2001, The Journal of Neuroscience.

[10]  S. Okada,et al.  Transplanted Hematopoietic Stem Cells from Bone Marrow Differentiate into Neural Lineage Cells and Promote Functional Recovery after Spinal Cord Injury in Mice , 2004, Journal of neuropathology and experimental neurology.

[11]  H. Deda,et al.  Treatment of chronic spinal cord injured patients with autologous bone marrow-derived hematopoietic stem cell transplantation: 1-year follow-up. , 2008, Cytotherapy.

[12]  M. Pittenger,et al.  Human mesenchymal stem cells modulate allogeneic immune cell responses. , 2005, Blood.

[13]  K. Kang,et al.  Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs , 2007, Journal of veterinary science.

[14]  D. Yoon,et al.  Human mesenchymal stem cell transplantation promotes functional recovery following acute spinal cord injury in rats. , 2007, Acta neurobiologiae experimentalis.

[15]  M. Kassem,et al.  Maintenance of differentiation potential of human bone marrow mesenchymal stem cells immortalized by human telomerase reverse transcriptase gene despite [corrected] extensive proliferation. , 2005, Biochemical and biophysical research communications.

[16]  S. Okada,et al.  Hematopoietic stem cell and marrow stromal cell for spinal cord injury in mice , 2005, Neuroreport.

[17]  C. Ide,et al.  Bone marrow stromal cells infused into the cerebrospinal fluid promote functional recovery of the injured rat spinal cord with reduced cavity formation , 2004, Experimental Neurology.

[18]  A. Caplan,et al.  Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidine , 1995, Muscle & nerve.

[19]  J. Kocsis,et al.  Remyelination of the Rat Spinal Cord by Transplantation of Identified Bone Marrow Stromal Cells , 2002, The Journal of Neuroscience.

[20]  D. Hackam,et al.  Translating animal research into clinical benefit , 2007, BMJ : British Medical Journal.

[21]  S. Both,et al.  Bone tissue-engineered implants using human bone marrow stromal cells: effect of culture conditions and donor age. , 2002, Tissue engineering.

[22]  Yi Li,et al.  Ischemic rat brain extracts induce human marrow stromal cell growth factor production , 2002, Neuropathology : official journal of the Japanese Society of Neuropathology.

[23]  B. Dobkin,et al.  Cellular Transplants in China: Observational Study from the Largest Human Experiment in Chronic Spinal Cord Injury , 2006, Neurorehabilitation and neural repair.

[24]  R. Deans,et al.  Mesenchymal stem cells: biology and potential clinical uses. , 2000, Experimental hematology.

[25]  A. Manira,et al.  Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  S. Ogawa,et al.  Cardiomyocytes can be generated from marrow stromal cells in vitro. , 1999, The Journal of clinical investigation.

[27]  C. Carlo-Stella,et al.  Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.

[28]  M. Schwartz.  Autoimmune involvement in CNS trauma is beneficial if well controlled. , 2000, Progress in brain research.

[29]  J. Wyndaele,et al.  Incidence, prevalence and epidemiology of spinal cord injury: what learns a worldwide literature survey? , 2006, Spinal Cord.

[30]  K. Leong,et al.  Hepatic differentiation potential of commercially available human mesenchymal stem cells. , 2006, Tissue engineering.

[31]  S. Salani,et al.  Neuroectodermal and microglial differentiation of bone marrow cells in the mouse spinal cord and sensory ganglia , 2002, Journal of neuroscience research.

[32]  G. Bumgardner,et al.  Genetic Modification of Hepatocytes towards Hepatocyte Transplantation and Liver Tissue Engineering , 2006, Cell transplantation.

[33]  O. Ringdén,et al.  HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells. , 2003, Experimental hematology.

[34]  N. Copeland,et al.  Insertional mutagenesis identifies genes that promote the immortalization of primary bone marrow progenitor cells. , 2005, Blood.

[35]  J. Fawcett,et al.  The glial scar and central nervous system repair , 1999, Brain Research Bulletin.

[36]  B. Min,et al.  Complete Spinal Cord Injury Treatment Using Autologous Bone Marrow Cell Transplantation and Bone Marrow Stimulation with Granulocyte Macrophage‐Colony Stimulating Factor: Phase I/II Clinical Trial , 2007, Stem cells.

[37]  P. Lesný,et al.  Bone Marrow Stem Cells and Polymer Hydrogels—Two Strategies for Spinal Cord Injury Repair , 2006, Cellular and Molecular Neurobiology.

[38]  S. Feng,et al.  Human umbilical cord mesenchymal stem cells and the treatment of spinal cord injury , 2009, Chinese medical journal.

[39]  M. Zurita,et al.  Bone marrow stromal cells can achieve cure of chronic paraplegic rats: Functional and morphological outcome one year after transplantation , 2006, Neuroscience Letters.

[40]  J. Peduzzi,et al.  Olfactory Mucosa Autografts in Human Spinal Cord Injury: A Pilot Clinical Study , 2006, The journal of spinal cord medicine.

[41]  Xiran Zhang,et al.  Mesenchymal Stern Cells from Adult Human Bone Marrow Differentiate into a Cardiomyocyte Phenotype In Vitro , 2004, Experimental biology and medicine.

[42]  M. Oudega,et al.  Transplantation of Schwann cells and olfactory ensheathing glia after spinal cord injury: does pretreatment with methylprednisolone and interleukin-10 enhance recovery? , 2004, Journal of neurotrauma.

[43]  N. Theodore,et al.  Stem cell biology and its therapeutic applications in the setting of spinal cord injury , 2008 .

[44]  P. Jorens,et al.  Can cell therapy heal a spinal cord injury? , 2008, Spinal Cord.

[45]  J. Skene.  Axonal growth-associated proteins. , 1989, Annual review of neuroscience.

[46]  Z. Zhao,et al.  Rat bone marrow mesenchymal stem cells differentiate into hepatocytes in vitro. , 2005, World journal of gastroenterology.

[47]  O. Lee,et al.  In vitro hepatic differentiation of human mesenchymal stem cells , 2004, Hepatology.

[48]  W. Tetzlaff,et al.  Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury , 2004, The Journal of comparative neurology.

[49]  M Chopp,et al.  Spinal cord injury in rat: treatment with bone marrow stromal cell transplantation , 2000, Neuroreport.

[50]  A I Caplan,et al.  A chemically defined medium supports in vitro proliferation and maintains the osteochondral potential of rat marrow-derived mesenchymal stem cells. , 1995, Experimental cell research.

[51]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[52]  A. Levi,et al.  Transplantation of human bone marrow-derived stromal cells into the contused spinal cord of nude rats. , 2008, Journal of neurosurgery. Spine.

[53]  M. Hájek,et al.  Transplantation of bone marrow stem cells as well as mobilization by granulocyte-colony stimulating factor promotes recovery after spinal cord injury in rats. , 2006, Journal of neurotrauma.

[54]  M. Chopp,et al.  Adult bone marrow stromal cells administered intravenously to rats after traumatic brain injury migrate into brain and improve neurological outcome , 2001, Neuroreport.

[55]  D. Prockop,et al.  Engraftment and migration of human bone marrow stromal cells implanted in the brains of albino rats--similarities to astrocyte grafts. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[56]  Ján Rosocha,et al.  Transplants of Human Mesenchymal Stem Cells Improve Functional Recovery After Spinal Cord Injury in the Rat , 2006, Cellular and Molecular Neurobiology.

[57]  Michael Y. Wang,et al.  Techniques for Aspirating Bone Marrow for Use in Spinal Surgery , 2005, Neurosurgery.

[58]  H. Okano,et al.  Transplantation of in vitro‐expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats , 2002, Journal of neuroscience research.

[59]  C. Ide,et al.  Bone marrow stromal cells enhance differentiation of cocultured neurosphere cells and promote regeneration of injured spinal cord , 2003, Journal of neuroscience research.

[60]  H. Winn,et al.  Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial , 1997 .

[61]  R. Ransohoff,et al.  Enhanced axonal growth into a spinal cord contusion injury site in a strain of mouse (129X1/SvJ) with a diminished inflammatory response , 2004, The Journal of comparative neurology.